Lymphopenic Community Acquired Pneumonia (L-Cap), an Immunological Phenotype Associated With Higher Risk of Mortality

EBioMedicine- Netherlands

doi 10.1016/j.ebiom.2017.09.023

Full Text

Abstract

Available in

Categories

Molecular Biology

Date

October 1, 2017

Authors

Jesus F. Bermejo-Martin

Albert Gabarrus

Rosario Menendez

Publisher

Elsevier BV

Related search

Severe Community-Acquired Pneumonia: Risk Factors for In-Hospital Mortality

Intensive Care Medicine

English

An Evaluation of Prescribing Practices for Community-Acquired Pneumonia (CAP) in Mongolia

BMC Health Services Research

English

One-Year Mortality in Patients With Community-Acquired Pneumonia

Journal of Respiratory Infections

English

The Science of Selecting Antimicrobials for Community-Acquired Pneumonia (CAP)

Journal of Managed Care Pharmacy

English

Immunological Reactivity Among Young Patients With Community-Acquired Pneumonia and Cytomegaloviral Persistence

Zaporozhye Medical Journal

English

The Risk Stratification in Community-Acquired Pneumonia

American Journal of Emergency Medicine

Emergency Medicine

English

Immunological Aspects of Cytomegalovirus Infection in Community-Acquired Pneumonia Among Young Adults.

Medicni perspektivi (Medical perspectives)

English

Community-Acquired Pneumonia

English

Community Acquired Pneumonia

Archives of Disease in Childhood

English